Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 1.0
ZIMMER BIOMET HOLDINGS, INC. reported year ending December 31, 2024 results: revenue 2024 Reported Revenue Change 4.5% - 5.5%, EPS Adjusted Diluted EPS $8.00 - $8.15. Guidance reaffirmed.
- Period
- year ending December 31, 2024
- Revenue
- 2024 Reported Revenue Change 4.5% - 5.5%
- EPS
- Adjusted Diluted EPS $8.00 - $8.15
- Guidance
- reaffirmed
- Result
- guidance update
Exact text from the filing
The Company is providing the following full-year 2024 financial guidance: Projected Year Ending December 31, 2024 2024 Reported Revenue Change 4.5% - 5.5%
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 1.0
ZIMMER BIOMET HOLDINGS, INC. reported quarter and year ended December 31, 2023 results: revenue Fourth quarter net sales of $1.940 billion; Full-year net sales of $7.394 billion, net income Net earnings for the fourth quarter were $419.2 million; For the full year, net earnings were $1.024 billion, EPS Diluted earnings per share were $2.01 for the fourth quarter; Full-year diluted earnings per share were $4.88.
- Period
- quarter and year ended December 31, 2023
- Revenue
- Fourth quarter net sales of $1.940 billion; Full-year net sales of $7.394 billion
- Net income
- Net earnings for the fourth quarter were $419.2 million; For the full year, net earnings were $1.024 billion
- EPS
- Diluted earnings per share were $2.01 for the fourth quarter; Full-year diluted earnings per share were $4.88
- Result
- reported results
Exact text from the filing
heather.zoumaslubeski@zimmerbiomet.com zach.weiner@zimmerbiomet.com Zimmer Biomet Announces Fourth Quarter and Full-Year 2023 Financial Results • Fourth quarter net sales of $1.940 billion increased 6.3% and 6.1% on a constant currency 1 basis • Fourth quarter diluted earnings per share were $2.01; adjusted 1 diluted earnings per share were $2.20 • Full-year net
View on SEC.gov